Company: ARVN
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001655759-25-000075
Chunk: 68

Company: ARVINAS, INC.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 68
---
 a period of up to 12 months following his or her date of termination, (3) a lump sum payment equal to 100% of his or her target bonus for the year in which his or her employment is terminated or, if higher, his or her target bonus immediately prior to the change in control, and (4) full vesting acceleration of his or her then-unvested equity awards, such that his or her equity awards become fully exercisable and non-forfeitable as of the termination date.

If any of Dr. Berkowitz’s, Dr. Cacace’s, Mr. Saik’s, Dr. Taylor’s or Dr. Teel’s, as applicable, employment is terminated for any other reason, including as a result of his or her death or disability, for cause, or voluntarily by him without good reason, our obligations under the employment agreement or understanding cease immediately, and he or she is only entitled to the accrued obligations.

Mr. Cassidy departed from the company in February 2024. Mr. Cassidy was entitled to the accrued obligations under this employment agreement.

#### Other Agreements
In connec tion with entering into initial employment with us, each of Dr. Houston, Mr. Cassidy, Dr. Berkowitz, Dr. Cacace, Mr. Saik, Dr. Taylor, and Dr. Teel signed a proprietary rights, non-disclosure, developments, non-competition and non-solicitation agreement. Under this agreement, each named executive officer agreed not to compete with us during his employment and for a period of one year afte r the termination of his or her employment, not to solicit our employees, consultants, or actual or prospective customers or business relations during his or her employment and for a period of one year after the termination of his or her employment, and to protect our confidential and proprietary information indefinitely. In addition, under this agreement, each named executive officer agreed that we own all inventions that are developed by such executive officer during his or her employment and that there is a presumption that we own inventions made by the executive officer during a period of six months after the termination of his or her employment that are related to the executive officer’s activities while employed by us. Each named executive officer also agreed to provide us with a non-exclusive, royalty-free, perpetual license for any prior inventions that such executive officer incorporates into any of our products, processes, research or development programs or other works in the course of such named executive officer’s employment with us.

<div align='center'>Potential Payments Upon